Cancer Control

RTOG R0831   Consent  QOL Consent  HIPAA    Protocol  

A Randomized, Double-Blinded, Placebo-Controlled Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase 5 Inhibitor, Tadalafil, in Prevention of Erectile Dysfunction in Patients Treated With Radiotherapy for Prostate Cancer

RTOG R0933     Consent    HIPAA    Protocol

A Phase II Trial of Hippocampal Avoidance During Whole-Brain Radiotherapy for Brain Metastasis

NCCTG N08C9  Consent   HIPAA    Protocol   

Phase III, Randomized, Study of Sulfasalazine versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

BRAIN

CTSU E3F05    Consent    HIPAA     Protocol    

Phase III Study of Radiation Therapy with or without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas

RTOG R0539  Consent    HIPAA     Protocol    (Group 1 closure 9/29/10) (Group II closure 5/12/2011)

Phase II Trial of Observation for Low-Risk Meningiomas and of Radiotherapy for Intermediate- and High-Risk

RTOG R0834   Screening Consent   Consent   HIPAA   Protocol

Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1P/19Q Deleted Anaplastic Glioma: the CATNON Intergroup Trial

       Brain Mets

NCCTG N0574  Consent   HIPAA    Protocol

Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in Patients with One to Three Cerebral Metastases

RTOG R0933     Consent    HIPAA    Protocol

A Phase II Trial of Hippocampal Avoidance During Whole-Brain Radiotherapy for Brain Metastasis

BREAST

NSABP B-39        Consent    HIPAA    Fast Facts     Protocol    (Closed to specific patients)

A Randomized Phase III Study of Conventional Whole Breast Irradiation versus Partial Breast Irradiation for Women with Stage 0, I or II Breast Cancer

RTOG R1014   Consent   HIPAA    Protocol  

A Phase II Study of Repeat Breast Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation for Local Recurrence of Breast Carcinoma

RTOG R1005   Consent    HIPAA    Protocol 

A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer

     Breast - Metastatic

GASTROINTESTINAL

  Colon - Rectal  

      Rectal

    Stomach

    Esophageal

RTOG R0436   Consent   HIPAA  Fast Facts   Protocol  Treatment Calendar Arm 1   Arm 2   

A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Who Are Treated Without Surgery

RTOG R1010   Consent    HIPAA  Fast Facts   Protocol  

A Phase III Trial Evaluating the Additon of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

    Pancreas

RTOG R0848  Consent    HIPAA  Fast Facts  Protocol                                                                                                    Treatment Calendar Arm 1 Arm 2  Arm 3(1)   Arm 3(2)  Arm 4(1)  Arm 4(2)

A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

    Gallbladder

GENITOURINARY

    Prostate

RTOG R0534  Consent     HIPAA   Fast Facts   Protocol  

A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPORT) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy

RTOG R0622     Consent     HIPAA     Protocol   

A Phase II Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy

RTOG R0815   Consent   HIPAA   Fast Facts   Protocol   

A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer

RTOG R0831   Consent      QOL Consent     HIPAA    Protocol  

A Randomized, Double-Blinded, Placebo-Controlled Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase 5 Inhibitor, Tadalafil, in Prevention of Erectile Dysfunction in Patients Treated With Radiotherapy for Prostate Cancer

   Bladder/Urothelium

RTOG R0524    Consent    HIPAA  Schema   Protocol  (temporary closure 10/26/11)

A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab with Daily Irradiation or Paclitaxel Alone with Daily Irradiation Following Tranurethral Surgery for Non-Cystectomy Candidates with Muscle-Invasive Bladder Cancer

    Germ Cell Malignancies

    Renal

GYNECOLOGIC

     Ovarian

     Cervical

    Endometrial

HEAD & NECK

RTOG R0920   Consent   HIPAA   Fast Facts   Protocol

 A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

RTOG R1016   Consent    HIPAA    Protocol

Phase III Trial of Radiotherapy Plus Cetuximab vs Chemotherapy in HPV-Associated Oropharynx Cancer

LEUKEMIA

    Acute Leukemia

    Chronic Leukemia

LUNG 

Non-Small Cell      

CTSU C30610   Consent    HIPAA    Fast Facts   Protocol    Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide

CTSU ACOSOG Z4099/RTOG 1021   Consent    HIPAA  Protocol  

A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) versus Stereotactic Body Radiation Therapy in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)

      Small Cell

RTOG R0937        Consent    HIPAA    Protocol 

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative  Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED_SCLC)

LYMPHOMA

    Hodgkin's

   Non-Hodgkin's

    Mantle Cell

Melanoma                                                       

Myeloma

Sarcoma 

Other   

RTOG R0631   Consent    HIPAA    Protocol  (Phase III open)

Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis

Return to the Top